Shares of Aptus Defined Risk ETF (BATS:DRSK – Get Free Report) traded up 1% during mid-day trading on Friday . The stock traded as high as $26.27 and last traded at $26.10. 259,867 shares traded hands during mid-day trading, The stock had previously closed at $25.84.
Aptus Defined Risk ETF Trading Up 1.0 %
The stock has a market cap of $461.97 million, a price-to-earnings ratio of 1.32 and a beta of 0.25. The company has a 50 day simple moving average of $26.24 and a 200-day simple moving average of $25.27.
Hedge Funds Weigh In On Aptus Defined Risk ETF
Institutional investors and hedge funds have recently modified their holdings of the stock. ORG Partners LLC acquired a new position in Aptus Defined Risk ETF during the 3rd quarter worth approximately $279,000. Park Place Capital Corp acquired a new stake in Aptus Defined Risk ETF during the 1st quarter worth about $4,809,000. Finally, Sugarloaf Wealth Management LLC grew its stake in Aptus Defined Risk ETF by 10.2% during the first quarter. Sugarloaf Wealth Management LLC now owns 2,280,858 shares of the company’s stock worth $60,808,000 after purchasing an additional 211,946 shares during the period.
Aptus Defined Risk ETF Company Profile
The Aptus Defined Risk ETF (DRSK) is an exchange-traded fund that mostly invests in target outcome asset allocation. The fund is an actively-managed fund that combines US corporate bond exposure with an overlay of call options on US large-cap stocks. The fund seeks income and capital appreciation. DRSK was launched on Aug 8, 2018 and is managed by Aptus.
Read More
- Five stocks we like better than Aptus Defined Risk ETF
- What is the FTSE 100 index?
- Appleās Earnings Show Investors Its Strength and Its Weakness
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
- The How and Why of Investing in Biotech Stocks
- DraftKings Q1: Strong Customer Acquisition and Product Innovation
Receive News & Ratings for Aptus Defined Risk ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptus Defined Risk ETF and related companies with MarketBeat.com's FREE daily email newsletter.